The UTHealth Behavioral Sciences Center, set to open next year, will be unlike anything in Houston. Rendering courtesy of Perkins and Will

Film and TV portrayals of psychiatric hospitals have driven a narrative based in cold, clinical rooms and unwelcoming corridors. That picture couldn't be more inaccurate when it comes to Houston's first public mental health hospital in more than three decades. Breaking stigmas and setting a new bar for design, the UTHealth Behavioral Sciences Center is set to open its doors in late 2021.

UTHealth has brought on architecture firm Perkins and Will to design the upcoming mental health facility. The behavioral health campus will be the largest facility of its kind in the United States, becoming a place to train future physicians and specialists. Located near Texas Medical Center, the space will consist of two buildings connected by a glazed bridge, surrounded by a tranquil green space.

The 220,000-square-foot facility includes 264 new inpatient beds and will provide access to mental healthcare, substance use intervention and treatment, and medical care via integrated treatment programs.

"Knowing that behavioral and mental health is a critical aspect of one's holistic well-being, our team was thoughtful in approaching each design decision through research and with the interest of promoting health," says Diana Davis, principal and managing director of the Houston studio of Perkins and Will.

Creating the calm

Rendering courtesy of Perkins and Will

Each element in the space was created with the intention of creating a peaceful environment for patients and staff. From a warm color palette to scenic views, the architecture will play a role in soothing patients and offering a relaxing space.

"We were working directly with a researcher who had done a lot of work on the impact of lighting environments for helping to establish a stronger sense of circadian rhythm in the behavioral health environment," explains Davis.

Tunable lighting fixtures that can shift to warmer hues at certain times of day were one of the intentional designs featured throughout the space.

Insomnia can arise in various mental health disorders and can even be a side effect of certain medications. According to the National Alliance on Mental Illness, approximately 50 percent of insomnia cases are related to depression, anxiety or psychological stress.

"If you've ever suffered from a little bit of insomnia, you can imagine that that probably makes the treatment process that much harder. So anything we could do as design professionals to encourage a relaxing, sleeping space was very important," says Sarah Rolfvondenbaumen, a project architect at Perkins and Will.

Like light, sound can be a crucial element in creating an ambiance. The units in the UTHealth Behavioral Sciences Center is built for 24 patients — now imagine 24 patients talking in a room. "It could get very loud," says Rolfvondenbaumen, "We focused a lot on how to reduce that sound."

Rolfvondenbaumen explained how many hospital settings use two different types of acoustics that are "necessary to make a good space to be in." Sound transmission class (STC) is the measurement of how sound travels between two different spaces, and noise reduction coefficient (NRC) is a number value that describes the average sound absorption of material.

"We used a very high in our NRC ceiling tile where applicable. . .that really helps capture the sound that is bouncing around a room and displacing it instead of reflecting it back down," says Rolfvondenbaumen. The design also changes the planes of the space, avoiding the typical square layout and giving rooms non-90 degree angles.

Perkins and Will will also be collaborating with researchers at the UTHealth Science Center to research the impact of noise reduction. By comparing the space patients are in now vs. the new building, Davis hopes to conduct "a study that would show that, hopefully, by reducing the noise that we're also able to reduce adverse events and contribute to that healing environment."

Materials matter

Rendering courtesy of Perkins and Will courtesy of Perkins and Will

Outside of choosing noise-reducing materials, Perkins and Will made a commitment to using sustainable items within the facility.

"We had a very rigorous process of selecting the interior finishes to make sure that they were good for the environment or at least good for the people who are living in the space," says Rolfvondenbaumen.

Material health was a big priority because "in trying to heal people's minds and bodies, we weren't subjecting them to materials that themselves might be carcinogens or involve an excess of pollutants in the process of being created," explains Davis.

A welcoming space

Rendering courtesy of Perkins and Will

"It was really important to us in the design to deinstitutionalize the look of the building," explains Davis, "To try to keep the height down so that it felt a little less intimidating so that it felt more like it was a part of its community."

To help patients transition from the hospital setting into the outside world, the campus includes a therapy mall. Offering opportunities for patients to practice interacting in everyday life, the therapy mall was created to be used in a multitude of ways. It can serve as a salon, boutique, fitness center, movie night spot, or music therapy space.

"One of my favorite features of the building is that the way it is designed is that the shared treatment spaces that are kind of the amenity spaces that serve multiple units are located on the ground floor and all wrap around one of the courtyards," explains Davis.

The common areas like the therapy mall and dining room feature natural light and picturesque views of the tree-filled courtyard. "We were very intentional about making sure that the key locations of therapy all had that direct communication to the outdoors and that ability to see out," says Davis.

Staff perks

Rendering courtesy of Perkins and Will

The healthcare field, especially during a pandemic, can be a stressful environment with high rates of employee burnout. The CDC has even published extensive guides for healthcare workers and first responders to help overcome the stress caused by COVID-19 and the healthcare system.

More than solely a relaxing space for patients, the UTHealth Behavioral Sciences Center is designed to make work comfortable for staff members, too. The facility's Support Pavilion holds an education center as well as break rooms, on-call sleep rooms, and a mother's room for staff.

"The Support Pavilion has its own entrance so that people coming and going are preapproved," explains Rolfvondenbaumen, "They have a badge reader so that they don't have to go through security scrutinization that the public entrance has."

Planning ahead

Rendering courtesy of Perkins and Will

Every Houstonian is, unfortunately, familiar with the city's flooding woes. The UTHealth Behavioral Sciences Center project started post-Hurricane Harvey, so flooding was undoubtedly on the mind of the Perkins and Will team.

Evacuating a healthcare building is unideal, especially a psychiatric facility. Measures were taken to prevent flooding and keep the hospital running on generator power, so patients could stay safe in the building. Just below the hospital, the facility features underground storage tanks that could fill an Olympic-sized swimming pool.

While weather can be planned for, a global pandemic is far less predictable. While the project with UTHealth was started prior to the coronavirus, the space is intentionally designed to allow patients to have flexibility throughout. Patients can choose to be in larger group settings or separate themselves into a breakout room, lending itself to social distancing guidelines.

While it's unclear whether Houston will be dealing with the COVID-19 pandemic at the close of next year, research shows the lasting mental health struggles the virus is creating. Davis foresees this project contributing "in a much more significant way" due to the unfortunate "need for care that we will have following this [pandemic] because of the mental stress and strain."

While mental and behavioral health has long-held stigmas, the UTHealth Behavioral Sciences Center will be both "welcoming and inviting," says Davis.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.